DDO activators are a specialized class of chemical compounds that target the enzymatic activity of D-aspartate oxidase, an enzyme responsible for the oxidative deamination of the amino acid D-aspartate. By either binding to the active site and mimicking the natural substrate or attaching to an allosteric site to alter the enzyme's conformation, these activators increase the catalytic action of DDO. This biochemical enhancement leads to an accelerated conversion of D-aspartate into its metabolites, which is a process intrinsic to the regulation of this non-proteinogenic amino acid in various biological systems. The structural diversity among DDO activators reflects the different approaches that can be taken to elevate enzyme activity, ranging from slight modifications of the D-aspartate molecule to complex designs that interact with DDO in more sophisticated ways.
While their primary role is to modulate the activity of DDO, these activators also contribute to the homeostasis of D-aspartate levels within cells and tissues. D-aspartate plays a significant role in neural signaling and endocrine functions, and its precise regulation is vital for maintaining normal physiological processes. The activators' ability to regulate the concentration of D-aspartate underscores the importance of their interaction with DDO. Despite the focus on DDO activation, the compounds may exhibit off-target interactions due to their varying affinities for similar enzymes or substrates within the cell, which adds a layer of complexity to their utilization and the understanding of their mechanism of action.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May demethylate DNA regions near the DDO gene, enhancing transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Could relax chromatin structure near DDO gene through histone acetylation, promoting gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Might increase DDO expression by inhibiting HDACs and activating transcription factors. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
May upregulate DDO by HDAC inhibition, leading to a more transcriptionally active chromatin state. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Could enhance DDO transcription via HDAC inhibition and subsequent chromatin remodeling. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Might promote DDO gene expression by altering histone acetylation patterns. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
May upregulate DDO through broad-spectrum HDAC inhibition, affecting gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Could hypothetically activate DDO expression by DNA demethylation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
May potentially upregulate DDO through selective HDAC inhibition. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Could indirectly increase DDO by modulating retinoid-responsive transcription factors. |